While some association exists between the occurrence of pancreatitis and dipeptidyl peptidase 4 inhibitors (DPP4i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) [5], there are only a few reports linking sodium-glucose co-transporter-2 inhibitors (SGLT-2is) with pancreatitis. Here, DPP4 is linked to pancreatitis.